bf/NASDAQ:RNA_icon.jpeg

COM:AVIDITYBIOSCIENCES

Avidity Biosciences

  • Stock

Last Close

42.56

22/11 21:00

Market Cap

5.16B

Beta: -

Volume Today

993.16K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
0.50
-
average payables
1.94M
-
1.15M
40.41%
2.32M
-
2.32M
0%
average receivables
1.05M
-
book value per share
-1.99
-
-3.16
58.91%
14.14
547.32%
9.21
34.87%
11.08
20.37%
6.86
38.11%
capex per share
-0.00
-
-0.01
379.59%
-0.05
343.64%
-0.09
79.09%
-0.05
40.05%
-0.06
7.00%
capex to depreciation
-0.13
-
-0.68
427.83%
-2.93
333.54%
-5.85
99.92%
-2.04
65.23%
0.46
122.65%
capex to operating cash flow
0.01
-
-0.09
1,959.62%
0.03
131.17%
0.04
34.08%
0.02
47.48%
0.04
71.41%
capex to revenue
-0.13
-
-0.10
21.62%
-0.16
58.77%
-0.40
149.25%
-0.31
23.68%
-0.44
44.51%
cash per share
0.15
-
4.57
2,960.78%
15.46
237.98%
11.84
23.37%
11.71
1.14%
8.15
30.36%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
2.59
-
0.05
98.04%
0.00
94.49%
0.03
876.46%
0.02
39.01%
0.02
6.31%
debt to equity
-0.25
-
-0.08
69.91%
0.00
104.06%
0.03
903.88%
0.02
39.88%
0.02
6.42%
dividend yield
0.00
-
0.00
346.60%
earnings yield
-0.02
-
-0.05
169.16%
-0.08
45.99%
-0.12
49.82%
-0.15
22.56%
-0.32
119.87%
enterprise value
596.67M
-
499.80M
16.24%
225.64M
54.85%
589.16M
161.11%
827.77M
40.50%
485.53M
41.34%
enterprise value over ebitda
-58.99
-
-29.43
50.11%
-5.10
82.68%
-4.99
2.07%
-4.63
7.30%
-2.06
55.46%
ev to operating cash flow
-61.80
-
200.72
424.80%
-6.08
103.03%
-6.21
2.22%
-6.07
2.24%
-4.08
32.87%
ev to sales
1.57K
-
215.52
86.31%
33.25
84.57%
63.17
90.02%
89.74
42.05%
50.79
43.41%
free cash flow per share
-0.47
-
0.11
123.24%
-1.76
1,717.68%
-2.38
34.87%
-2.67
12.09%
-1.69
36.67%
free cash flow yield
-0.02
-
0.00
123.24%
-0.07
1,906.58%
-0.10
44.80%
-0.12
20.07%
-0.19
55.28%
graham net net
-2.03
-
-3.27
61.08%
14.18
533.23%
10.73
24.33%
10.54
1.72%
6.40
39.27%
graham number
5.08
-
10.51
106.81%
25.41
141.82%
24.23
4.66%
28.43
17.35%
21.18
25.50%
income quality
0.86
-
-0.10
111.69%
0.84
931.24%
0.80
3.99%
0.78
2.52%
0.56
28.36%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
-14.62
-
-2.35
83.95%
-211.85
8,929.24%
31.44
-
interest debt per share
0.53
-
0.60
11.61%
0.05
91.11%
0.28
434.71%
0.10
66.16%
0.13
40.86%
inventory turnover
invested capital
-0.25
-
-0.08
69.91%
0.00
104.06%
0.03
903.88%
0.02
39.88%
0.02
6.42%
market cap
589.44M
-
589.44M
0%
552.84M
6.21%
984.74M
78.12%
1.16B
17.54%
660.76M
42.91%
net current asset value
-41.87M
-
-66.59M
59.04%
304.00M
556.54%
364.99M
20.06%
562.22M
54.04%
483.52M
14.00%
net debt to ebitda
-0.72
-
5.28
838.00%
7.39
40.01%
3.35
54.66%
1.84
45.01%
0.74
59.64%
net income per share
-0.58
-
-1.55
169.16%
-2.03
30.73%
-2.83
39.54%
-3.24
14.41%
-2.91
10.33%
operating cash flow per share
-0.47
-
0.12
125.79%
-1.71
1,523.14%
-2.29
33.57%
-2.61
14.15%
-1.63
37.58%
payables turnover
receivables turnover
research and ddevelopement to revenue
22.26
-
6.27
71.83%
5.54
11.63%
10.85
95.83%
16.31
50.29%
19.98
22.51%
return on tangible assets
-3.00
-
-0.33
88.94%
-0.13
60.26%
-0.27
108.39%
-0.26
3.58%
-0.34
27.56%
revenue per share
0.02
-
0.11
511.87%
0.31
179.42%
0.23
28.15%
0.18
21.45%
0.13
25.95%
roe
0.29
-
0.49
69.38%
-0.14
129.22%
-0.31
114.24%
-0.29
4.95%
-0.42
44.89%
roic
0.36
-
0.37
3.41%
-0.14
138.00%
-0.29
104.39%
-0.29
0.10%
-0.45
55.27%
sales general and administrative to revenue
6.44
-
2.20
65.77%
1.98
10.02%
2.81
41.61%
4.09
45.64%
5.67
38.57%
shareholders equity per share
-1.99
-
-3.16
58.91%
14.14
547.32%
9.21
34.87%
11.08
20.37%
6.86
38.11%
stock based compensation to revenue
0.16
-
0.18
10.59%
0.64
262.72%
1.83
187.99%
2.94
60.88%
4.00
35.89%
tangible asset value
-41.13M
-
-65.36M
58.91%
306.22M
568.54%
381.43M
24.56%
578.08M
51.55%
500.76M
13.37%
tangible book value per share
-1.99
-
-3.16
58.91%
14.14
547.32%
9.21
34.87%
11.08
20.37%
6.86
38.11%
working capital
-1.37M
-
85.44M
6,318.34%
317.09M
271.13%
381.48M
20.31%
571.03M
49.69%
530.63M
7.08%

All numbers in (except ratios and percentages)